Navigation Links
Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference
Date:6/18/2009

SAN DIEGO, June 18, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Piper Jaffray Fourth Annual Europe Conference on June 23, 2009 at 9:30 a.m. British Summer Time (4:30 am Eastern Time, 1:30 a.m. Pacific Time) at the Andaz Hotel in London. Dominic P. Behan, Ph.D., Arena's Senior Vice President and Chief Scientific Officer, is scheduled to provide an overview of the company, including its clinical development and research programs.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Look
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals to Receive $100 Million from Deerfield Management
2. New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia
3. Arena Pharmaceuticals to Present at the 34th Annual Deutsche Bank Health Care Conference
4. Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints
5. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
6. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
7. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
9. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
10. Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference
11. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... (PRWEB) August 22, 2014 BambooIndustry.com is ... industry. The company has recently unveiled its new collection ... are specially made for customers who are looking for ... of them are offered with great savings (up to ... consumers can access these cheap products. , The ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Living in ... the atmosphere that comes along with it. A quality ... sure that such amenities are available. , ... in Fayetteville, Georgia and Community Association Management, LLC made ... American Parks Company to provide an additional amenity for ...
(Date:8/21/2014)... Recently, Van Uden Center has noticed ... is on the rise and much of that ... Fiscal Times, young people are becoming more accepting ... The Fiscal Times published an article on July ... medicine. The article can be found at ...
(Date:8/21/2014)... arteries of chronic kidney disease patients may be a ... new study in the Journal of the American ... the Johns Hopkins Bloomberg School of Public Health assert ... of subclinical atherosclerosis in predicting the risk of heart ... percent of all patients with chronic kidney disease (CKD) ...
(Date:8/21/2014)... appear to have better survival if they are ... Uchechukwu C. Megwalu, M.D., M.P.H., of the Ichan ... and colleagues. , Background: Approximately 11,000 to 13,000 ... and squamous cell carcinoma accounts for the vast ... surgical removal of the larynx with postoperative radiation ...
Breaking Medicine News(10 mins):Health News:Buy Elegant Bamboo Floorings from Internationally Well-known Supplier BambooIndustry.com 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Van Uden Center Sees Growth in Alternative Medicine 2Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2
... half say unreimbursed loss of as little as $500 ... May 7 As unemployment rates continue to climb, ... their access to affordable insurance. In a national recent ... insurance services, nearly two-thirds of respondents admitted to living ...
... Danaher Corporation (NYSE: DHR ) ... approved a regular quarterly dividend of $0.03 per ... of record on June 26, 2009.Danaher Corporation is ... Industrial Technologies and Tools and Components ( ...
... , , Fiscal third quarter revenue ... quarter a year ago , , , , ... were a record $0.50 per share , , , , ... revenue increased by $46 million or 12% , , , ...
... Abaxis, Inc. (Nasdaq: ABAX ), a medical ... Don Wood, chief operations officer, will present at the Bank ... Thursday, May 14, 2009 at 10:00 a.m. ET. The conference ... City.Interested investors are invited to listen to a live audio ...
... 7 STERIS Corporation (NYSE: STE ) today ... increase in its quarterly dividend to $0.11 per common share. ... of record at the close of business on May 21, ... Corporation is to provide a healthier today and safer tomorrow ...
... Care Collaborative is the National Organization Dedicated ... Fla. May 7 The Quantum Group, ... the Executive Committee of the Patient-Centered Primary ... collaboration of major employers, consumer groups, patient ...
Cached Medicine News:Health News:Affinion Group Survey Reveals That Underinsured Consumers Need Alternate Solutions in Light of Current Economic Climate 2Health News:Affinion Group Survey Reveals That Underinsured Consumers Need Alternate Solutions in Light of Current Economic Climate 3Health News:Perrigo Reports Record Third Quarter 2Health News:Perrigo Reports Record Third Quarter 3Health News:Perrigo Reports Record Third Quarter 4Health News:Perrigo Reports Record Third Quarter 5Health News:Perrigo Reports Record Third Quarter 6Health News:Perrigo Reports Record Third Quarter 7Health News:Perrigo Reports Record Third Quarter 8Health News:Perrigo Reports Record Third Quarter 9Health News:Perrigo Reports Record Third Quarter 10Health News:Perrigo Reports Record Third Quarter 11Health News:Perrigo Reports Record Third Quarter 12Health News:Perrigo Reports Record Third Quarter 13Health News:Perrigo Reports Record Third Quarter 14Health News:Perrigo Reports Record Third Quarter 15Health News:Perrigo Reports Record Third Quarter 16Health News:Perrigo Reports Record Third Quarter 17Health News:Perrigo Reports Record Third Quarter 18Health News:Perrigo Reports Record Third Quarter 19Health News:Perrigo Reports Record Third Quarter 20Health News:Perrigo Reports Record Third Quarter 21Health News:Perrigo Reports Record Third Quarter 22Health News:Abaxis, Inc. to Present at Bank of America and Merrill Lynch 2009 Health Care Conference 2Health News:STERIS Corporation Announces Quarterly Dividend Increase of 38% 2Health News:STERIS Corporation Announces Quarterly Dividend Increase of 38% 3Health News:The Quantum Group Joins Executive Committee of the Patient-Centered Primary Care Collaborative 2Health News:The Quantum Group Joins Executive Committee of the Patient-Centered Primary Care Collaborative 3Health News:The Quantum Group Joins Executive Committee of the Patient-Centered Primary Care Collaborative 4Health News:The Quantum Group Joins Executive Committee of the Patient-Centered Primary Care Collaborative 5Health News:The Quantum Group Joins Executive Committee of the Patient-Centered Primary Care Collaborative 6
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 32,890 ...
(Date:8/20/2014)... , Aug. 20, 2014 ... research report is available in its ... Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html Given the ... (HAIs), demand has increased for solutions ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6
... MedNet Solutions, a global life sciences technology solutions ... pleased to announce that iMedNet™ EDC , ... solution, is now commercially available.   ... and easy-to-use web-based solution that allows non-technical research ...
... 2011 Reportlinker.com announces that a new market research ... Top 200 Biopharmaceuticals Industry Report (Global) ... Biopharmaceuticals Industry Report Plimsoll Publishing Ltd. ... the Global Biopharmaceuticals Industry. Using the unique Plimsoll method ...
Cached Medicine Technology:MedNet Solutions Announces the Release of iMedNet EDC 2Reportlinker Adds Top 200 Biopharmaceuticals Industry Report (Global) 2Reportlinker Adds Top 200 Biopharmaceuticals Industry Report (Global) 3Reportlinker Adds Top 200 Biopharmaceuticals Industry Report (Global) 4
... 800 Series KTP/YAG Surgical Laser System ... It is a high-power, dual-wavelength system ... surgery, orthopedics, general surgery, neurosurgery, pulmonary ... beam surgically cuts, vaporizes and coagulates ...
... of 532 nm lasers are distinguished from ... solid-state design. A compact and sealed ... and reliable for a broad range of ... hemoglobin and an adjustable pulse length, the ...
... Ceralas D15/810 diode laser is a versatile ... many soft tissue applications. With excellent hemostatic ... a flexible fiber optic delivery system that ... dry environments alike.,Compact and portable, the Ceralas ...
... monoclonal antibody based colorimetric test intended ... gonorrhoeae. The test requires less than ... heating or pretreatment. The test does ... cultures. GonoGen&trade II eliminates agglutination, guesswork, ...
Medicine Products: